Erschienen in:
16.10.2022 | ASO Author Reflections
ASO Author Reflections: Multimodality Treatment of Cutaneous Angiosarcoma
verfasst von:
Sophie J. M. Reijers, MD, Winan J. van Houdt, MD, PhD, MSc
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 1/2023
Einloggen, um Zugang zu erhalten
Excerpt
Cutaneous angiosarcoma (cAS) carries a poor prognosis and is often subdivided into subtypes based on etiology. There is limited survival data on cAS treated with curative-intent surgery since most studies describe outcomes of all different AS subtypes and stages.
1 This study aimed to evaluate oncological outcome of cAS patients with all subtypes of resectable primary cAS treated with surgical resection in specialized sarcoma centers. …